NCT04722510

Brief Summary

Patients with a main diagnosis of borderline personality disorder will be recruited and will be randomized for the application of low frequency repeated transcranial magnetic stimulation (rTMS) protol or sham rTMS protocol. A pre-treatment and post-treatment measurement of the severity of BPD symptoms, impulsivity, and aggressive behavior will be carried out in all participants using self-administered questionnaires. All participants will be asked to participate in a passing ball game (Cyberball) with the intention of investigating aspects related to social inclusion / exclusion and measurements will be made regarding planning using the maze test. Participation in the Cyberball and the assessment of the planning will be carried out before and after the application of the treatment protocol.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 21, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

January 21, 2021

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 21, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 21, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 25, 2021

Completed
Last Updated

January 25, 2021

Status Verified

January 1, 2021

Enrollment Period

Same day

First QC Date

January 21, 2021

Last Update Submit

January 21, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Maneuver effect

    To determine whether the application of a series of 15 sessions of low-frequency (1 Hz) repeated Transcranial Magnetic Stimulation applied to the right dorsolateral prefrontal cortex reduces the severity of impulse agressive behavior in subjects with BPD as measured by the impulsive / premeditated aggression scale.

    3 weeks

Study Arms (1)

Effect of repeated TMS on aggressive impulse behavior in patients with BPD.

EXPERIMENTAL

A protocol of 15 sessions of repeated Transcranial Magnetic Stimulation at 1 Hz on right dorsolateral prefrontal cortex.

Device: repeated transcranial magnetic stimulation

Interventions

Transcranial magnetic stimulation is a non-invasive brain modulation technique that has proven to be a useful study and treatment tool in neuropsychiatric disorders. This technique allows to increase (with high frequency protocol, \> 1 Hz) or decrease (with low frecuency protocols, 1 hz or less) neuronal excitability in a focused cortical area.

Effect of repeated TMS on aggressive impulse behavior in patients with BPD.

Eligibility Criteria

Age18 Years - 59 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Outpatient consultant in the Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz.
  • Main diagnosis of borderline personality disorder according to DSM-IV-TR.
  • In the case of having some type of pharmacological treatment using SSRIs, antipsychotics and / or anticonvulsants, this should be maintained without modifications for at least 2 weeks prior to the start of the study and during the follow-up period.
  • Comorbidity with some other personality disorder according to the SCID-II, with the exception of antisocial personality disorder.
  • Acceptance of participation in the study by signing the informed consent.

You may not qualify if:

  • Subjects who did not agree to participate.
  • Diagnosis of current antisocial personality disorder, bipolar disorder, psychotic disorders, severe major depressive episode, substance use disorder (except nicotine), and post-traumatic stress disorder.
  • Presence of any comorbid neurological disorder.
  • Diagnosis of intellectual disability.
  • Subjects in whom the use of rTMS is contraindicated: history of seizures, pregnancy, presence of pacemaker, heart disease, and presence of a metallic object.
  • Electroencephalographic evidence of some type of abnormality in the excitability of the central nervous system (dysrhythmias, paroxysmal activity, graphical elements suggestive of epileptic activity, etc.).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto Nacional de Psiquiatria Ramon de la Fuente Muñiz

Mexico City, Mexico City, 14370, Mexico

RECRUITING

MeSH Terms

Conditions

Borderline Personality Disorder

Condition Hierarchy (Ancestors)

Personality DisordersMental Disorders

Study Officials

  • JORGE GONZALEZ-OLVERA, PHD

    Instituto Nacional de Psiquiatría Ramon de la Fuente Muñiz

    STUDY CHAIR

Central Study Contacts

ANDRES RODRIGUEZ-DELGADO, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Randomized clinical trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 21, 2021

First Posted

January 25, 2021

Study Start

January 21, 2021

Primary Completion

January 21, 2021

Study Completion

January 21, 2021

Last Updated

January 25, 2021

Record last verified: 2021-01

Locations